PHF23 and non-small cell lung carcinoma: Ming Cheng et al. pointed out that the overexpression of PHF23 significantly increased the chemoresistance of NSCLC cells to chemotherapeutic drugs and enhanced the DNA damage repair ability, which further promoted the malignant progression of NSCLC (Cheng et al., 2023).